Real-time enrollment status for this hyper ige syndrome from stat3 mutation clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:08 AM UTC
| NCT Number | NCT07262983 |
| Recruiting Status | Recruiting |
| Condition | Hyper IgE Syndrome From STAT3 Mutation |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | July 16, 2026 (2 days ago) |
As of July 18, 2026: Clinical trial NCT07262983 is currently recruiting participants. This phase1 study for hyper ige syndrome from stat3 mutation is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07262983 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07262983 was last updated 2 days ago (July 16, 2026). HelloStudys verifies this status automatically.